From October 1, 2023 to December 31, 2023, the company has repurchased 512,262 shares, representing 0.69% for $177.02 million. With this, the company has completed the repurchase of 1,265,661 shares, representing 1.71% for $438.34 million under the buyback announced on February 16, 2023.
West Pharmaceutical Services, Inc.
Equities
WST
US9553061055
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
331.7 USD | +0.93% | -6.74% | -5.81% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.81% | 24.16B | |
-5.56% | 181B | |
-0.11% | 108B | |
-6.17% | 66.12B | |
+2.64% | 50.65B | |
+6.58% | 43.66B | |
+4.91% | 41.3B | |
+21.98% | 31.6B | |
+14.45% | 25.03B | |
-4.35% | 23.95B |
- Stock Market
- Equities
- WST Stock
- News West Pharmaceutical Services, Inc.
- Tranche Update on West Pharmaceutical Services, Inc.'s Equity Buyback Plan announced on February 16, 2023.